Advertisement
Screener

GSK plc (GLAXF) Form 6-K: Report of foreign private issuer, 2020, Page 2

GSK plc Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2020-04-06: Form 6-K; Period of report 2020-04-06; Description GSK AND VIR BIOTECHNOLOGY ENTER COLLABORATION; Document a9237i.htm.
  • 2020-04-01: Form 6-K; Period of report 2020-04-01; Description GSK COMPLETES DIVESTMENT OF HORLICKS; Document a4364i.htm.
  • 2020-04-01: Form 6-K; Period of report 2020-04-01; Description TOTAL VOTING RIGHTS; Document a4086i.htm.
  • 2020-03-30: Form 6-K; Period of report 2020-03-30; Description CONSUMER HEALTHCARE PRODUCT SALES CATEGORY CHANGES; Document a1046i.htm.
FiledFormPeriod of reportDescriptionDocument
2020-04-066-K2020-04-06GSK AND VIR BIOTECHNOLOGY ENTER COLLABORATIONa9237i.htm
2020-04-016-K2020-04-01GSK COMPLETES DIVESTMENT OF HORLICKSa4364i.htm
2020-04-016-K2020-04-01TOTAL VOTING RIGHTSa4086i.htm
2020-03-306-K2020-03-30CONSUMER HEALTHCARE PRODUCT SALES CATEGORY CHANGESa1046i.htm
2020-03-246-K2020-03-24PUBLICATION OF AGM NOTICEa2929h.htm
2020-03-206-K2020-03-20DIRECTORATE CHANGEa0531h.htm
2020-03-186-K2020-03-18DIRECTOR/PDMR SHAREHOLDINGa6481g.htm
2020-03-136-K2020-03-13EMTN PROSPECTUS SUPPLEMENT UPDATEa1760g.htm
2020-03-116-K2020-03-11DIRECTOR/PDMR SHAREHOLDINGa8353f.htm
2020-03-096-K2020-03-09DIRECTOR/PDMR SHAREHOLDINGa4903f.htm
2020-03-096-K2020-03-09PUBLICATION OF GSK 2019 FORM 20-Fa3600f.htm
2020-03-046-K2020-03-04ANNUAL FINANCIAL REPORTa0299f.htm
2020-03-026-K2020-03-02TOTAL VOTING RIGHTSa6789e.htm
2020-02-216-K2020-02-21DIRECTOR/PDMR SHAREHOLDINGa7805d.htm
2020-02-206-K2020-02-20DIRECTOR/PDMR SHAREHOLDINGa6577d.htm
2020-02-206-K2020-02-20DIRECTOR/PDMR SHAREHOLDINGa6481d.htm
2020-02-206-K2020-02-20DIRECTOR/PDMR SHAREHOLDINGa6485d.htm
2020-02-196-K2020-02-19DIRECTOR/PDMR SHAREHOLDINGa5248d.htm
2020-02-196-K2020-02-19DIRECTOR/PDMR SHAREHOLDINGa5178d.htm
2020-02-196-K2020-02-19DIRECTOR/PDMR SHAREHOLDINGa5186d.htm
2020-02-196-K2020-02-19DIRECTOR/PDMR SHAREHOLDINGa5172d.htm
2020-02-196-K2020-02-19DIRECTOR/PDMR SHAREHOLDINGa5163d.htm
2020-02-126-K2020-02-12DIRECTOR/PDMR SHAREHOLDINGa8251c.htm
2020-02-116-K2020-02-11DIRECTOR/PDMR SHAREHOLDINGa6646c.htm
2020-02-116-K2020-02-11TRANSFER OF TREASURY SHARESa5497c.htm
2020-02-066-K2020-02-06DIRECTOR/PDMR SHAREHOLDINGa2545c.htm
2020-02-056-K2020-02-05DIRECTOR/PDMR SHAREHOLDINGa1101c.htm
2020-02-056-K2020-02-05FINAL RESULTSa0670c.htm
2020-02-036-K/A2020-02-03GSK PUBLISHES PROVISIONAL 2020 DIVIDEND DATESa7971b.htm
2020-02-036-K2020-02-03TOTAL VOTING RIGHTSa7321b.htm
2020-01-156-K2020-01-15DIRECTOR/PDMR SHAREHOLDINGa8062z.htm
2020-01-146-K2020-01-14DIRECTOR/PDMR SHAREHOLDINGa7973z.htm
2020-01-146-K2020-01-14DIRECTOR/PDMR SHAREHOLDINGa7924z.htm
2020-01-136-K2020-01-13DIRECTOR/PDMR SHAREHOLDINGa6632z.htm
2020-01-136-K2020-01-13DIRECTOR/PDMR SHAREHOLDINGa6176z.htm
2020-01-136-K2020-01-13DIRECTOR/PDMR SHAREHOLDINGa6050z.htm
2020-01-136-K2020-01-13DIRECTOR/PDMR SHAREHOLDINGa5969z.htm
2020-01-086-K2020-01-08GSK ANNOUNCES ADDITION TO CORPORATE EXECUTIVE TEAMa1928z.htm
2020-01-086-K2020-01-08GSK PUBLISHES PROVISIONAL 2020 DIVIDEND DATESa2044z.htm
2020-01-026-K2020-01-02TOTAL VOTING RIGHTSa5391y.htm